Scott J. Leffler insider trades

Open-market stock purchases and sales by Scott J. Leffler, Chief Financial Officer at Myriad Genetics Inc, from SEC Form 4 filings since Nov 20, 2020.

Recent trades

No open-market trades in the last 12 months.

Companies traded

  • MYGN Myriad Genetics Inc: other filings, last Mar 14, 2025
  • CLOV Clover Health Investments, Corp /DE: other filings, last Jan 25, 2024
  • SHC Sotera Health Co: other filings, last Mar 2, 2022

Get free alerts when Scott J. Leffler files a new trade →